Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IOC 2027

Macular Degeneration at IOC 2027

Part of the IOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Macular Degeneration Session

Macular degeneration is a progressive eye condition affecting the central part of the retina, known as the macula. This area is crucial for sharp, central vision needed for activities like reading and driving. There are two types: dry macular degeneration, characterized by the gradual thinning of the macular tissue, and wet macular degeneration, marked by abnormal blood vessel growth under the retina.

Risk factors include aging, genetics, smoking, and prolonged sun exposure. Symptoms may include blurry or distorted central vision, straight lines appearing wavy, and difficulty recognizing faces. While there is no cure, early detection through regular eye exams is crucial for managing the condition and preventing severe vision loss. Treatment options vary depending on the type and severity, ranging from dietary supplements and lifestyle changes to injections or laser therapy for wet macular degeneration. Ongoing research aims to develop more effective therapies to preserve vision and improve quality of life for those affected.

Topics Covered in Macular Degeneration

Topic 01

Dry AMD & Geographic Atrophy

Topic 02

Neovascular Wet AMD

Topic 03

Drusen

Topic 04

Anti-VEGF Therapy

Topic 05

Amsler Grid Monitoring

Topic 06

Genetic & Smoking Risk Factors

Related Scientific Sessions at IOC 2027

Why Attend the Macular Degeneration Conference 2027

Earn CPD Credit

Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.

Present Your Research

Oral and poster slots for original Macular Degeneration work, reviewed by the scientific committee.

Network Globally

Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.

Publish & Get Indexed

Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.

Learn from Keynotes

Plenary lectures from leading voices shaping Macular Degeneration research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IOC 2027 for the Macular Degeneration track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Macular Degeneration Conference 2027 — FAQs

What is the Macular Degeneration track at IOC 2027?

The Macular Degeneration track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Macular Degeneration. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Macular Degeneration sessions?

Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Macular Degeneration are all welcome — whether presenting or attending.

Can I present my research in the Macular Degeneration track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Macular Degeneration sessions?

Yes. IOC 2027 is a hybrid conference — attend the Macular Degeneration track in person in Singapore or join live online, with on-demand access afterward.

Join the IOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us